The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Requirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Abstract
After DNA damage, many cells appear to enter a sustained arrest in the G 2 phase of the cell cycle. It is shown here that this arrest could be sustained only when p53 was present in the cell and capable of transcriptionally activating the cyclin-dependent kinase inhibitor p21. After disruption of either the p53 or the p21 gene, γ radiated cells progressed into mitosis and exhibited a G 2 DNA content only because of a failure of cytokinesis. Thus, p53 and p21 appear to be essential for maintaining the G 2 checkpoint in human cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [149]
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [55]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
Self-citationp21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Universal control mechanism regulating onset of M-phase
Nurse, P. (1990) · Nature · doi:10.1038/344503a0 · Cited by 2,798
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,539
p53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,490
Self-citationPeng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341
Is a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citation
Research works printed but not linked: 13
- Kastan M. B., Onyekwere O., Sidransky D., Vogelstein B., Craig R. W., Cancer Res. 51, 6304 (1991);
- Waldman T., Kinzler K. W., Vogelstein B., Cancer Res. 55, 5187 (1995).
- Powell S. N., et al., Cancer Res. 55, 1643 (1995);
- Fan S., et al., Cancer Res. 55, 1649 (1995);
- Russell K. J., et al., ibid. 55, 1639 (1995).
- Khan S. H., Wahl G. M., Cancer Res. 58, 396 (1998);
- Michieli P., et al., Cancer Res. 54, 3391 (1994);
- Paules R. S., et al., Cancer Res 55, 1763 (1995);
- Stewart N., Hicks G. G., Paraskeva F., Mowat M., Oncogene 10, 109 (1995).
- Li Y., Jenkins C. W., Nichols M. A., Xiong Y., Oncogene 9, 2261 (1994).
- Niculescu A. B., et al., Mol. Cell. Biol. 18, 629 (1998). · DOI
- El-Deiry W. S., et al., Cancer Res. 55, 2910 (1995);
- Kaufmann K., et al., Cell Growth. Diff. 8, 1105 (1997);
Cited by
Sorted by citations
Items 601–700 of 1,018
Ii, T., Satomi, Y., Katoh, D., Shimada, J., Baba, M., Okuyama, T., Nishino, H., & Kitamura, N. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.10.023 · Cited by 97
Zhu, B., Vemavarapu, L. K., Thompson, W. J., & Strada, S. J. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20286 · Cited by 97
PTENGene Targeting Reveals a Radiation-Induced Size Checkpoint in Human Cancer Cells
Lee, C. S., Kim, J.-S., & Waldman, T. A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1767 · Cited by 97
Self-citationp53 α-Helix mimetics antagonize p53/MDM2 interaction and activate p53
Chen, L., Yin, H. H., Farooqi, B., Sebti, S. M., Hamilton, A. D., & Chen, J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0342 · Cited by 97
Vychytilova‐Faltejskova, P., Merhautová, J., Macháčková, T., Gutierrez, I., García‐Solano, J., Radová, L., Brchnelová, D., Slabá, K., Svoboda, M., Halámková, J., et al. (2017) · Oncogenesis · doi:10.1038/s41389-017-0006-6 · Cited by 96
A limited number of double-strand DNA breaks is sufficient to delay cell cycle progression
van den Berg, J., Manjón, A. G., Kielbassa-Elkadi, K., Feringa, F. M., Freire, R., & Medema, R. H. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky786 · Cited by 101
Maeda, T., Hanna, A. N., Sim, A. B., Chua, P., Chong, M. T., & Tron, V. A. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01781.x · Cited by 96
Kaestner, P., Stolz, A., & Bastians, H. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0323 · Cited by 98
Cell cycle control in the kidney
Thomasová, D., & Anders, H. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu395 · Cited by 96
Analysis of nuclear transport signals in the human apurinic/apyrimidinic endonuclease (APE1/Ref1)
Jackson, E. B. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki641 · Cited by 95
Laine, H., Doetzlhofer, A., Mantela, J., Ylikoski, J. S., Laiho, M., Roussel, M. F., Segil, N., & Pirvola, U. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4956-06.2007 · Cited by 96
Kawanami, D., Mahabeleshwar, G. H., Lin, Z., Atkins, G. B., Hamik, A., Haldar, S. M., Maemura, K., LaManna, J. C., & Jain, M. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025346 · Cited by 97
Rogulski, K. R., Li, Y., Rothermund, K. D., Pu, L., Watkins, S. C., Yi, F., & Prochownik, E. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208897 · Cited by 96
Kaliski, A., Maggiorella, L., Cengel, K. A., Mathé, D., Rouffiac, V., Opolon, P., Lassau, N., Bourhis, J., & Deutsch, É. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0179 · Cited by 95
5-Fluorouracil Enhances Exosome-Dependent Accumulation of Polyadenylated rRNAs
Fang, F., Hoskins, J. W., & Butler, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10766-10776.2004 · Cited by 95
Tumor Suppressor Activity of AP2α Mediated through a Direct Interaction with p53
McPherson, L. A., Loktev, A. V., & Weigel, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208924200 · Cited by 95
Soria, G., Speroni, J., Podhajcer, O. L., Prives, C., & Gottifredi, V. (2008) · Journal of Cell Science · doi:10.1242/jcs.027730 · Cited by 94
Yoon, H., Liyanarachchi, S., Wright, F. A., Davuluri, R. V., Lockman, J. C., de la Chapelle, A., & Pellegata, N. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242597299 · Cited by 95
Gatifloxacin Induces S and G2-Phase Cell Cycle Arrest in Pancreatic Cancer Cells via p21/p27/p53
Yadav, V., Sultana, S., Yadav, J., & Saini, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047796 · Cited by 94
Comparison of oxaliplatin‐ and curcumin‐mediated antiproliferative effects in colorectal cell lines
Howells, L. M., Mitra, A., & Manson, M. M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22645 · Cited by 95
Vance, S. M., Pollom, E. L., Zhao, L., Parsels, J. D., Parsels, L. A., Brown, J. L., Maybaum, J., Lawrence, T. S., & Morgan, M. A. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18661 · Cited by 94
Self-citationYang, H. J., Chung, D.-H., Kim, Y. B., Choi, Y. H., & Moon, Y. (2007) · Toxicology · doi:10.1016/j.tox.2007.10.002 · Cited by 94
West, L. E., Roy, S., Weiner, K., Hayashi, R., Shi, X., Appella, E., Kutateladze, T. G., & Gozani, O. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139527 · Cited by 94
Guiducci, C., Cerone, M. A., & Bacchetti, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204145 · Cited by 94
Identification of ANKRD11 as a p53 coactivator
Neilsen, P. M., Cheney, K. M., Li, C.-W., Chen, J. D., Cawrse, J. E., Schulz, R. B., Powell, J. A., Kumar, R., & Callen, D. F. (2008) · Journal of Cell Science · doi:10.1242/jcs.026351 · Cited by 94
Pleiotropic defects in TCR signaling in a Vav‐1‐null Jurkat T‐cell line
Cao, Y., Janssen, E., Duncan, A. W., Altman, A., Billadeau, D. D., & Abraham, R. T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf499 · Cited by 94
Zhang, H., Xu, J., Long, Y., Maimaitijiang, A., Su, Z., Li, W., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312928 · Cited by 97
Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations
Funk, J. S., Klimovich, M., Drangenstein, D., Pielhoop, O., Hunold, P., Borowek, A., Noeparast, A., Pavlakis, E., Neumann, M. M., Balourdas, D.-I., et al. (2025) · Nature Genetics · doi:10.1038/s41588-024-02039-4 · Cited by 94
Maitra, A., Hansel, D. E., Argani, P., Ashfaq, R., Rahman, A., Naji, A., Deng, S., Geradts, J., Hawthorne, L., House, M. G., et al. (2003) · PubMed · Cited by 93
Yang, D., Tan, M., Wang, G., & Sun, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034079 · Cited by 94
p53-dependent gene repression through p21 is mediated by recruitment of E2F4 repression complexes
Benson, E. K., Mungamuri, S. K., Attie, O., Kracikova, M., Sachidanandam, R., Manfredi, J. J., & Aaronson, S. A. (2013) · Oncogene · doi:10.1038/onc.2013.378 · Cited by 100
Goldstone, S. D., Pavey, S. J., Forrest, A. R. R., Sinnamon, J., & Gabrielli, B. G. (2001) · Oncogene · doi:10.1038/sj.onc.1204177 · Cited by 93
Tse, A. N., & Schwartz, G. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0841 · Cited by 94
Yan, C., Wang, H., & Boyd, D. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112069200 · Cited by 93
Jackson, M. W., Agarwal, M. K., Yang, J., Bruss, P., Uchiumi, T., Agarwal, M. L., Stark, G. R., & Taylor (2005) · Journal of Cell Science · doi:10.1242/jcs.02307 · Cited by 92
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells
R�os, S., Flöter, J., Kaymak, I., Costa, C. D., Houddane, A., Dubuis, S., Griffiths, B. L., Mitter, R., Walz, S., Blake, S., et al. (2017) · Oncogene · doi:10.1038/onc.2016.477 · Cited by 96
Regulation of hematopoietic stem cell growth
Attar, E. C., & Scadden, D. T. (2004) · Leukemia · doi:10.1038/sj.leu.2403515 · Cited by 96
Nucleolin inhibits Hdm2 by multiple pathways leading to p53 stabilization
Saxena, A. D., Rorie, C. J., Dimitrova, D. D., Daniely, Y., & Borowiec, J. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209714 · Cited by 94
The human box C/D snoRNAs U3 and U8 are required for pre-rRNA processing and tumorigenesis
Langhendries, J.-L., Nicolas, E., Doumont, G., Goldman, S., & Lafontaine, D. L. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11148 · Cited by 92
Chopin, V., Slomianny, C., Hondermarck, H., & Bourhis, X. L. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.038 · Cited by 92
Redox modulation of the DNA damage response
Caputo, F., Vegliante, R., & Ghibelli, L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.022 · Cited by 95
Aggarwal, M., Banerjee, T., Sommers, J. A., Iannascoli, C., Pichierri, P., Shoemaker, R. H., & Brosh, R. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2975 · Cited by 91
Jung, P., & Hermeking, H. (2009) · Cell Cycle · doi:10.4161/cc.8.7.7949 · Cited by 94
Baskar, R., Sparatore, A., Soldato, P. D., & Moore, P. K. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.029 · Cited by 91
Duplan, E., Giaime, E., Viotti, J., Sévalle, J., Corti, O., Brice, A., Ariga, H., Qi, L., Checler, F., & da Costa, C. A. (2013) · Journal of Cell Science · doi:10.1242/jcs.127340 · Cited by 91
c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis
Arango, D., Mariadason, J. M., Wilson, A. J., Yang, W., Corner, G. A., Nicholas, C., Aranes, M., & Augenlicht, L. H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601338 · Cited by 91
Hayward, R. L., Macpherson, J. S., Cummings, J., Monia, B. P., Smyth, J. F., & Jodrell, D. I. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.169.3.2 · Cited by 91
p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth
Sun, H., Li, L., Li, W., Yang, F., Zhang, Z., Liu, Z., & Du, W. (2021) · EMBO Reports · doi:10.15252/embr.202152537 · Cited by 90
p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA
Yu, F., Bracken, C. P., Pillman, K. A., Lawrence, D., Goodall, G. J., Callen, D. F., & Neilsen, P. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129190 · Cited by 92
Involvement of Centrosome Amplification in Radiation-Induced Mitotic Catastrophe
Dodson, H., Wheatley, S. P., & Morrison, C. G. (2007) · Cell Cycle · doi:10.4161/cc.6.3.3834 · Cited by 96
Yang, D., Cao, A., Shi, J., Yin, P., Wang, L., Ji, G., Xie, J., & Wu, D. (2014) · Oncology Reports · doi:10.3892/or.2014.3034 · Cited by 90
Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon
Poole, A. J., Heap, D., Carroll, R. E., & Tyner, A. L. (2004) · Oncogene · doi:10.1038/sj.onc.1207994 · Cited by 90
Carcinogenesis, cancer therapy and chemoprevention
Blagosklonny, M. V. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401610 · Cited by 90
Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells
Mahyar-Roemer, M., Köhler, H., & Roemer, K. (2002) · BMC Cancer · doi:10.1186/1471-2407-2-27 · Cited by 90
Zhu, Y., He, W., Gao, X., Li, B., Mei, C., Xu, R., & Chen, H. (2015) · Scientific Reports · doi:10.1038/srep17730 · Cited by 91
Le, M., Fernández-Palomo, C., McNeill, F. E., Seymour, C. B., Rainbow, A. J., & Mothersill, C. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173685 · Cited by 89
Cancer cells use self-inflicted DNA breaks to evade growth limits imposed by genotoxic stress
Larsen, B. D., Benada, J., Yung, P. Y. K., Bell, R. A. V., Pappas, G. D., Urban, V., Ahlskog, J. K., Kuo, T. T., Janščák, P., Megeney, L. A., et al. (2022) · Science · doi:10.1126/science.abi6378 · Cited by 90
Islaih, M., Halstead, B. W., Kadura, I. A., Li, B., Reid‐Hubbard, J. L., Flick, L. M., Altizer, J. L., Deahl, J. T., Monteith, D., Newton, R. K., et al. (2005) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2005.04.012 · Cited by 89
Negishi, M., Wongpalee, S. P., Sarkar, S., Park, J.-H., Lee, K. Y., Shibata, Y., Reon, B. J., Abounader, R., Suzuki, Y., Sugano, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095216 · Cited by 89
Cell Cycle Regulation and p53 Activation by Protein Phosphatase 2Cα
Ofek, P., Ben‐Meir, D., Kariv-Inbal, Z., Oren, M., & Lavi, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211699200 · Cited by 89
p53 Functions in Endothelial Cells to Prevent Radiation-Induced Myocardial Injury in Mice
Lee, C., Moding, E. J., Cuneo, K. C., Li, Y., Sullivan, J. M., Mao, L., Washington, I. R., Jeffords, L. B., Rodrigues, R. C., Ma, Y., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002918 · Cited by 91
Regulation of the Mitotic and Meiotic Cell Cycles in the Male Germ Line
Wolgemuth, D. J. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.75 · Cited by 89
Li, Z., Xia, L., Lee, L. M., Khaletskiy, A., Wang, J., Wong, J. Y. C., & Li, J. J. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0543:egaimh]2.0.co;2 · Cited by 91
Cózar‐Castellano, I., Weinstock, M. T., Haught, M., Velázquez-García, S., Sipula, D., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-0632 · Cited by 90
Wei, W., Herbig, U., Wei, S., Dutriaux, A., & Sedivy, J. M. (2003) · The EMBO Reports · doi:10.1038/sj.embor.7400001 · Cited by 88
Self-citationKaymak, I., Maier, C. R., Schmitz, W., Campbell, A. D., Dankworth, B., Ade, C. P., Walz, S., Paauwe, M., Kalogirou, C., Marouf, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0650 · Cited by 90
Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells
Kowalski, S., Wyrzykowski, D., & Inkielewicz‐Stępniak, I. (2020) · Molecules · doi:10.3390/molecules25071757 · Cited by 88
Zhao, F., Siu, M. K. Y., Jiang, L., Tam, K. F., Ngan, H. Y. S., Le, X. F., Wong, O. G. W., Wong, E. S. Y., Gomes, A. R., Bella, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113478 · Cited by 88
Agapova, L. S., Chernyak, B. V., Domnina, L. V., Dugina, V. B., Efimenko, A. Y., Fetisova, E. K., Ivanova, O. Y., Kalinina, N., Хромова, Н. В., Kopnin, B. P., et al. (2008) · Biochemistry (Moscow) · doi:10.1134/s0006297908120031 · Cited by 88
Bettayeb, K., Baunbæk, D., Delehouzé, C., Loaëc, N., Hole, A. J., Baumli, S., Endicott, J., Douc‐Rasy, S., Bénard, J., Oumata, N., et al. (2010) · Genes & Cancer · doi:10.1177/1947601910369817 · Cited by 91
Homogeneous tetracycline-regulatable gene expression in mammalian fibroblasts
Izumi, M., & Gilbert, D. M. (2000) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(20000201)76:2 · Cited by 40
Flatt, P. M., Polyák, K., Tang, L. J., Scatena, C. D., Westfall, M. D., Rubinstein, L. A., Yu, J., Kinzler, K. W., Vogelstein, B., Hill, D. E., et al. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00441-9 · Cited by 89
Self-citationCRISPR-Cas9–based target validation for p53-reactivating model compounds
Wanzel, M., Vischedyk, J. B., Gittler, M. P., Gremke, N., Seiz, J. R., Hefter, M., Noack, M., Savai, R., Mernberger, M., Charles, J. P., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1965 · Cited by 87
Fábián, Z., Csatary, C. M., Szeberényi, J., & Csatáry, L. K. (2007) · Journal of Virology · doi:10.1128/jvi.02490-06 · Cited by 87
Mao, C. D., Hoang, P., & DiCorleto, P. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101188200 · Cited by 87
Modulation of the Cell Division Cycle by Human Papillomavirus Type 18 E4
Nakahara, T., Nishimura, A., Tanaka, M., Ueno, T., Ishimoto, A., & Sakai, H. (2002) · Journal of Virology · doi:10.1128/jvi.76.21.10914-10920.2002 · Cited by 87
Accumulation of soluble and nucleolar-associated p53 proteins following cellular stress
Klibanov, S. A., O’Hagan, H. M., & Ljungman, M. E. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1867 · Cited by 88
Aoyagi, K., Tatsuta, T., Nishigaki, M., Akimoto, S., Tanabe, C., Omoto, Y., Hayashi, S., Sakamoto, H., Sakamoto, M., Yoshida, T., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02967-4 · Cited by 87
Common Fragile Sites: Genomic Hotspots of DNA Damage and Carcinogenesis
Ma, K., Qiu, L., Mrasek, K., Zhang, J., Liehr, T., Quintana, L. G., & Li, Z. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130911974 · Cited by 86
Al-Aamri, H. M., Ku, H., Irving, H. R., Tucci, J., Meehan-Andrews, T., & Bradley, C. (2019) · BMC Cancer · doi:10.1186/s12885-019-5377-y · Cited by 86
Periostin Promotes Cell Proliferation and Macrophage Polarization to Drive Repair after AKI
Kormann, R., Kavvadas, P., Placier, S., Vandermeersch, S., Dorison, A., Dussaule, J., Chadjichristos, C. E., Prakoura, N., & Chatziantoniou, C. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019020113 · Cited by 86
Genistein induces radioprotection by hematopoietic stem cell quiescence
Davis, T. A., Mungunsukh, O., Zins, S. R., Day, R. M., & Landauer, M. R. (2008) · International Journal of Radiation Biology · doi:10.1080/09553000802317778 · Cited by 86
Gao, Y., Kitagawa, K., Hiramatsu, Y., Kikuchi, H., Isobe, T., Shimada, M., Uchida, C., Hattori, T., Oda, T., Nakayama, K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2629 · Cited by 86
Krüppel-like factor 4 prevents centrosome amplification following γ-irradiation-induced DNA damage
Yoon, H. S., Ghaleb, A. M., Nandan, M. O., Hisamuddin, I. M., Dalton, W. B., & Yang, V. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208576 · Cited by 88
p53 Promotes Cell Survival due to the Reversibility of Its Cell-Cycle Checkpoints
Lukin, D. J., Carvajal, L. A., Liu, W.-J., Resnick‐Silverman, L., & Manfredi, J. J. (2014) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0177 · Cited by 86
Zhang, X., Mukerji, R., Samadi, A. K., & Cohen, M. S. (2011) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-11-84 · Cited by 88
Saussurea lappa induces G2-growth arrest and apoptosis in AGS gastric cancer cells
Ko, S., Kim, H., Jin, D.-H., Bae, H., Kim, S. H., Park, C.-H., & Lee, S. E. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.06.026 · Cited by 86
Li, Y.-X., Himaya, S. W. A., Dewapriya, P., Zhang, C., & Kim, S. (2013) · Marine Drugs · doi:10.3390/md11125063 · Cited by 89
Identification of a Functional Domain in a GADD45-mediated G2/M Checkpoint
Yang, Q., Manicone, A. M., Coursen, J. D., Linke, S. P., Nagashima, M., Forgues, M., & Wang, X. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005319200 · Cited by 86
Ray, A., Milum, K., Battu, A., Wani, G., & Wani, A. A. (2013) · DNA Repair · doi:10.1016/j.dnarep.2013.01.003 · Cited by 85
“It has been shown that following damage induction p53 functions to arrest cells at either G1/S or G2/M boundary [54, 55].”
BackgroundTherapeutic targeting of C-terminal binding protein in human cancer
Straza, M. W., Paliwal, S., Kovi, R. C., Rajeshkumar, B. R., Trenh, P., Parker, D., Whalen, G. F., Lyle, S. R., Schiffer, C. A., & Grossman, S. R. (2010) · Cell Cycle · doi:10.4161/cc.9.18.12936 · Cited by 85
Effects of Histone Deacetylase Inhibitors on HIF-1
Liang, D., Kong, X., & Sang, N. (2006) · Cell Cycle · doi:10.4161/cc.5.21.3409 · Cited by 85
p53-dependent and p53-independent anticancer effects of different histone deacetylase inhibitors
Sonnemann, J., Marx, C., Becker, S., Wittig, S., Palani, C. D., Krämer, O. H., & Beck, J. F. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.742 · Cited by 87
Muñoz-Alonso, M. J., Acosta, J. C., Richard, C., Delgado, M. D., Sedivy, J. M., & León, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500758200 · Cited by 85
Self-citationTherapeutic Exploitation of Checkpoint Defects in Cancer Cells Lacking p53 Function
Dixon, H., & Norbury, C. J. (2002) · Cell Cycle · doi:10.4161/cc.1.6.257 · Cited by 85
Yang, J., Ahmed, A., Poon, E., Perusinghe, N. P., Brandon, A. D. H., Box, G., Valenti, M. R., Eccles, S. A., Rouschop, K. M. A., Wouters, B. G., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00959-08 · Cited by 86
Nongenotoxic p53 Activation Protects Cells against S-Phase–Specific Chemotherapy
Kranz, D., & Dobbelstein, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1527 · Cited by 85
Sp1 and p73 activate PUMA following serum starvation
Ming, L., Sakaida, T., Yue, W., Jha, A., Zhang, L., & Yu, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn150 · Cited by 86
A systematic RNAi synthetic interaction screen reveals a link between p53 and snoRNP assembly
Krastev, D. B., Slabicki, M. M., Paszkowski‐Rogacz, M., Hubner, N. C., Junqueira, M., Shevchenko, A., Mann, M., Neugebauer, K. M., & Buchholz, F. (2011) · Nature Cell Biology · doi:10.1038/ncb2264 · Cited by 88
Lin, C. C., Lin, S. Y., Chung, J., Lin, J., Chen, G. W., & Kao, S. T. (2006) · PubMed · Cited by 85
Metadata
- Authors
- Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- F. Bunz, S. Zhou, B. Vogelstein, The Howard Hughes Medical Institute and The Johns Hopkins Oncology Center, 424 North Bond Street, Baltimore, MD 21231, USA. C. Lengauer and K. W. Kinzler, The Johns Hopkins Oncology Center, Baltimore, MD 21231, USA. A. Dutriaux, J. P. Brown, J. Sedivy, Department of Molecular Biology, Cell Biology, and Biochemistry, Division of Biology and Medicine, Brown University, Providence, RI 02912, USA. T. Waldman, Program in Human Genetics and the Johns Hopkins Oncology...
- Corresponding author
- Vogelstein, B.
- Venue
- Science
- Published
- 1998-11-20
- Volume
- 282
- Issue
- 5393
- Pages
- 1497-1501
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2080125477
- Cited by
- 2,803
- References
- 50
- Citations by year
- 2026: 28 · 2025: 39 · 2024: 42 · 2023: 60 · 2022: 69 · 2021: 86 · 2020: 77 · 2019: 76 · 2018: 98 · 2017: 101 · 2016: 103 · 2015: 97 · 2014: 113 · 2013: 155 · 2012: 120
- FWCI
- 41.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA 57345, CA43460, P50CA062924, CA 62924)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p53, p21, G2 checkpoint, DNA damage, cell cycle arrest, cyclin-dependent kinase inhibitors, transcriptional activation, gamma radiation, cytokinesis, mitosis, gene disruption
- MeSH terms
- Cell Line, DNA, DNA Damage, Gamma Rays, Gene Expression Regulation, Humans, Mitosis, Mutation, Tumor Cells, Cultured, Nocodazole, Genes, p53, Tumor Suppressor Protein p53, G2 Phase, CDC2 Protein Kinase, Cyclins, Apoptosis, Cyclin B, Cyclin-Dependent Kinase Inhibitor p21, Cyclin B1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review